Table 1 Clinicopathological characteristics of the patients in the study cohort
From: High expression of p62/SQSTM1 predicts shorter survival for patients with pancreatic cancer
Variable | All cases |
|---|---|
Patients, n | 33 |
Median age, years (range) | 62 (50–80) |
Age, n (%) | |
<65 years | 20 (60.6) |
≥65 years | 13 (39.4) |
Sex, n (%) | |
Female | 15 (45.5) |
Male | 18 (54.5) |
Tumor location, n (%) | |
Head | 30 (90.9) |
Others | 3 (9.1) |
Tumor stage, n (%) | |
pT1 | 3 (9.1) |
pT2 | 13 (39.4) |
pT3 | 14 (42.4) |
pT4 | 3 (9.1) |
Differentiation, n (%) | |
Low | 10 (30.3) |
Medium | 14 (42.4) |
High | 5 (15.2) |
Data missing | 4 (12.1) |
Lymph node metastasis, n (%) | |
N0 | 15 (45.5) |
N1 | 18 (54.5) |
Adjuvant chemotherapy, n (%) | |
No | 26 (78.8) |
Yes | 7 (21.2) |